[Cardio-tranquilizing agents. A new therapeutic concept].
D001161:Arteriosclerosis / Q000188:drug therapy*; D002395:Catecholamines / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000188:drug therapy*; D004562:Electrocardiography; D005227:Fatty Acids / Q000097:blood; D013006:Growth Hormone / Q000097:blood; D006331:Heart Diseases / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007328:Insulin / Q000097:blood; D008055:Lipids / Q000097:blood; D011433:Propranolol / Q000627:therapeutic use*; D012119:Respiration / Q000187:drug effects
D002395:Catecholamines; D005227:Fatty Acids; D007328:Insulin; D008055:Lipids; D013006:Growth Hormone; D002784:Cholesterol; D011433:Propranolol; D006854:Hydrocortisone
La cardio-tranquillisation. Un nouveau concept thérapeutique.